middl
east
respiratori
syndrom
coronaviru
merscov
continu
caus
zoonot
infect
seriou
diseas
primarili
arabian
peninsula
due
repeat
spillov
dromedari
camel
subsequ
nosocomi
transmiss
approv
mer
vaccin
use
anim
human
current
avail
merscov
replic
requir
virusencod
papainlik
proteas
pl
pro
cleav
multipl
site
viral
replicas
polyprotein
therebi
releas
function
nonstructur
protein
addit
pl
pro
deubiquitin
enzym
dub
remov
ubiquitin
like
moieti
substrat
presum
counteract
host
antivir
respons
previou
work
determin
crystal
structur
merscov
pl
pro
complex
ubiquitin
facilit
design
pl
pro
mutat
impair
dub
activ
without
affect
viral
polyprotein
cleavag
introduc
dubinactiv
mutat
viral
genom
examin
impact
merscov
infect
cell
cultur
lethal
mous
model
although
overal
replic
dubneg
wildtyp
wt
recombin
merscov
compar
multipl
cell
line
infect
dubneg
viru
markedli
increas
mrna
level
interferon
ifn
ifnstimul
gene
moreov
compar
wt
viru
infect
surviv
rate
significantli
increas
dubneg
merscov
use
infect
transgen
mice
express
human
merscov
receptor
interestingli
dubneg
wt
merscov
replic
titer
lung
infect
mice
dubneg
viru
clear
faster
like
due
observ
acceler
betterregul
innat
immun
respons
contrast
delay
subsequ
excess
respons
wt
virusinfect
mice
studi
provid
first
direct
evid
dub
activ
coronavir
proteas
contribut
innat
immun
evas
profoundli
enhanc
virul
anim
model
thu
reduct
remov
innat
immunesuppress
dub
activ
pl
pro
promis
strategi
coronaviru
attenu
context
ration
vaccin
develop
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
immun
respons
modul
ubsystem
exampl
express
virusencod
dub
vdub
ligas
hijack
block
activ
host
dub
ligas
coronavirus
positivestrand
rna
virus
larg
genom
highli
conserv
organ
first
twothird
genom
encod
replicas
polyprotein
yield
nonstructur
protein
nsp
follow
cleavag
internallyencod
proteas
structur
accessori
protein
express
remain
onethird
genom
use
nest
set
viral
subgenom
rna
produc
infect
cell
follow
target
amplifi
normfind
softwar
identifi
suitabl
normal
gene
quantif
done
use
standard
curv
method
use
standard
dilut
seri
includ
qpcr
furthermor
data
normal
rel
quantiti
mrna
mrna
level
wtinfect
set
signific
rel
wt
calcul
use
unpair
student
ttest
p
valu
consid
statist
signific
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
promot
homogen
sampl
centrifug
x
g
min
supernat
collect
thereaft
rmerscov
titer
determin
plaqu
assay
cell
describ
statist
signific
p
wt
rmerscov
titer
determin
use
unpair
student
ttest
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
preserv
integr
rna
lung
soak
rnalat
thermo
fischer
scientif
directli
harvest
store
rna
extract
lung
transfer
gentlemac
tube
contain
ml
buffer
macherynagel
supplement
tissu
dissoci
gentlemac
dissoci
use
program
miltenyi
biotec
subsequ
sampl
centrifug
x
g
min
supernat
aliquot
rna
isol
follow
standard
protocol
nucleospin
rna
ii
kit
macherynagel
rtqpcr
analysi
perform
describ
follow
deviat
measur
mrna
level
triplex
qpcr
taqman
probe
perform
hotstartaq
master
mix
qiagen
wherea
target
amplifi
use
genespecif
primer
set
itaq
sybr
green
supermix
biorad
primer
probe
sequenc
request
obtain
cdna
also
use
verifi
substitut
merscov
pl
pro
retain
sever
round
viru
replic
mice
pcr
sequenc
determin
pl
pro
code
sequenc
execut
describ
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
rang
done
ad
twofold
dilut
start
dilut
cov
cell
calcul
use
spearman
method
viru
neutral
test
perform
twice
mean
two
measur
use
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
previou
work
describ
amino
acid
substitut
ubbind
site
merscov
pl
pro
specif
disrupt
dub
activ
without
affect
overal
proteolyt
activ
wt
rmerscov
cell
line
fig
plaqu
mutant
compar
size
wt
control
howev
combin
substitut
doubl
tripl
mutant
plaqu
size
variabl
averag
slightli
decreas
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
test
fig
b
also
mutant
yield
titer
compar
wt
viru
h
pi
cell
infect
moi
fig
notabl
rmerscov
peak
titer
approxim
fig
essenti
similar
result
obtain
dubneg
mutant
test
fig
suggest
overal
replic
human
cell
affect
substitut
wt
rmerscov
fig
doubl
mutant
show
pronounc
increas
singl
mutat
affect
mrna
level
qpcr
target
fig
also
cell
infect
virus
carri
substitut
induc
low
respons
compar
wt
viru
fig
wildtyp
mutant
viral
genom
rna
level
similar
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
infect
cell
fig
multicycl
infect
cell
rmerscov
induc
higher
level
isg
mrna
wt
viru
viperin
fig
g
even
pronounc
doubl
mutant
addit
substitut
unexpectedli
reduc
isg
respons
rel
doubl
mutant
fig
addit
effect
impli
substitut
combin
reduc
ubbind
pl
pro
mutant
gener
respons
compar
wt
viru
viru
genom
level
similar
fig
interestingli
merscov
genom
level
lower
cell
infect
doubl
tripl
mutant
compar
wt
viru
multicycl
infect
fig
aim
investig
rmerscov
infect
transgen
mice
respect
lethal
innat
immun
respons
lung
end
mice
infect
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
intranas
pfu
either
wt
dubneg
rmerscov
wherea
third
group
mice
mockinfect
group
contain
total
mice
anim
per
group
euthan
earli
time
point
remain
four
anim
three
group
monitor
period
day
assess
surviv
measur
bodi
weight
daili
basi
four
mice
infect
wt
rmerscov
die
euthan
reach
human
endpoint
day
pi
fig
contrast
one
four
mice
infect
dubneg
rmerscov
die
day
pi
three
mice
surviv
full
period
fig
even
small
number
anim
use
experi
differ
surviv
mice
infect
wt
dubneg
rmerscov
statist
signific
rank
test
p
valu
wt
dubneg
rmerscovinfect
mice
lost
weight
cours
infect
fig
three
surviv
mice
infect
dubneg
rmerscov
weight
loss
revers
day
pi
forward
fig
measur
rmerscov
replic
innat
immun
respons
virus
elicit
lung
infect
mice
euthan
four
anim
group
day
pi
lung
remov
part
materi
homogen
use
viru
titrat
wt
rmerscov
progeni
titer
approxim
pfu
per
g
lung
tissu
first
four
day
infect
fig
dubneg
viru
reach
similar
viru
titer
wt
control
first
two
day
pi
indic
viru
also
replic
well
mice
unexpectedli
howev
prove
imposs
recov
viru
lung
three
mice
infect
dubneg
cov
twice
day
pi
group
day
pi
group
fig
consequ
remain
unclear
whether
three
anim
success
inocul
dubneg
infect
mice
euthan
day
pi
virusposit
lung
titer
significantli
lower
wt
virusinfect
mice
time
point
fig
suggest
dub
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
neg
viru
clear
faster
lung
wt
rmerscov
viru
titer
also
determin
mice
die
infect
day
pi
survivor
infect
day
day
pi
rmerscov
wt
titer
around
pfu
per
g
lung
tissu
signifi
viru
titer
decreas
time
fig
viru
titer
singl
mous
die
dubneg
viru
infect
pfu
per
g
lung
tissu
fig
viru
could
recov
lung
mice
surviv
infect
dubneg
rmerscov
day
fig
order
verifi
whether
dubinactiv
substitut
merscov
mutant
stabli
maintain
anim
experi
sequenc
pl
pro
code
region
genom
perform
end
lung
tissu
homogen
rna
isol
pl
pro
code
sequenc
amplifi
rtpcr
sequenc
wt
virusinfect
mice
consensu
sequenc
pcr
product
found
ident
sequenc
bacbas
cdna
clone
rmerscov
launch
data
shown
rtpcr
sequenc
success
use
rna
isol
mice
infect
dubneg
rmerscov
also
dubneg
rmerscov
recov
fig
reveal
presenc
substitut
pl
pro
without
addit
substitut
pl
pro
data
shown
virusspecif
pcr
product
could
obtain
lung
mice
found
neg
infecti
viru
day
pi
data
shown
fig
one
mous
inocul
dubneg
rmerscov
although
viru
could
isol
day
pi
fig
isg
cytokin
control
activ
inflammatori
cytokin
chemokin
fig
first
day
infect
mrna
level
target
similarli
low
wt
dubneg
rmerscovinfect
mice
fig
day
pi
transcript
level
wt
infect
mice
compar
mockinfect
mice
clear
increas
measur
dubneg
rmerscovinfect
mice
fig
eas
visual
mean
fold
increas
target
present
fig
although
statist
significantli
higher
mock
wt
virusinfect
mice
fig
b
mrna
level
found
slightli
elev
wt
rmerscovinfect
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mice
rel
mockinfect
mice
even
pronounc
increas
seen
neg
rmerscovinfect
mice
fig
day
pi
differ
innat
immun
respons
mice
seen
compar
respons
day
pi
fig
dubneg
viru
group
increas
innat
immun
transcript
slightli
lower
rel
day
pi
fig
variat
mrna
level
four
mice
smaller
group
day
day
pi
fig
compar
show
howev
strong
increas
transcript
level
test
target
day
pi
especi
mrna
level
remark
upregul
fig
b
f
togeth
demonstr
day
pi
mrna
level
innat
immun
factor
cytokin
chemokin
alreadi
downregul
dubneg
infect
mice
contrast
strong
upregul
observ
rmerscov
wtinfect
mice
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mani
viral
proteas
primari
role
viru
replic
evolv
target
host
cell
protein
often
accessori
cleavag
event
indirectli
affect
viral
replic
pathogenesi
coronavir
pl
pro
constitut
strike
exampl
kind
dual
function
cleav
multipl
site
replicas
polyprotein
part
also
deconjug
ub
ublik
modifi
presum
suppress
innat
immun
respons
studi
dub
activ
context
covinfect
cell
difficult
pl
pro
function
reli
enzymat
activ
site
inactiv
without
kill
viru
replic
therefor
earlier
research
explor
altern
approach
select
inactiv
dub
activ
merscov
pl
pro
base
avail
crystal
structur
pl
pro
ub
complex
disrupt
enzym
ubbind
site
minim
affin
ub
base
assay
carri
express
system
conclud
dub
activ
pl
pro
could
inde
inactiv
almost
complet
without
affect
proteolyt
activ
need
viral
polyprotein
cleavag
subsequ
studi
suggest
dub
activ
mer
cov
pl
pro
may
inde
involv
suppress
innat
immun
respons
dubneg
pl
pro
longer
abl
downregul
promot
activ
engin
mutant
neg
virus
therebi
convincingli
extend
observ
merscov
infectedcel
cultur
vivo
character
replic
innat
immun
respons
virus
induc
comparison
wt
viru
interestingli
dubneg
virus
specif
contain
substitut
induc
higher
level
isg
mrna
wt
viru
cell
confirm
role
pl
pro
innat
immun
suppress
demonstr
infect
fig
howev
upregul
type
ifn
respons
reduc
progeni
titer
dubneg
cov
cell
fig
observ
plaqu
size
rmerscov
contain
substitut
slightli
smaller
compar
wt
viru
fig
suggest
mutant
viru
somehow
affect
also
multicycl
infect
merscov
genom
level
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
reduc
upon
infect
dubneg
merscov
carri
substitut
fig
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
inocul
merscov
replic
observ
lung
wt
rmerscov
titer
stabl
first
four
day
infect
show
pfu
per
g
lung
tissu
fig
although
lower
previous
report
peak
titer
day
pi
pfu
per
g
lung
tissu
infect
lethal
also
hand
mice
die
day
infect
fig
like
mice
succumb
infect
also
merscov
infect
brain
howev
experiment
circumst
allow
us
take
sampl
support
assumpt
strikingli
infect
dubneg
viru
result
significantli
increas
surviv
compar
anim
infect
wt
viru
fig
dubneg
viru
reach
titer
lung
wt
viru
day
pi
drop
significantli
day
pi
stay
high
wt
virusinfect
mice
fig
futur
research
interest
determin
whether
histopatholog
reduc
mice
infect
dubneg
rmerscov
confirm
earlier
viru
clearanc
reduc
tissu
damag
correl
increas
surviv
rel
wt
virusinfect
mice
messeng
rna
level
ifn
isg
inflammatori
cytokin
start
rise
lung
dubneg
rmerscovinfect
mice
day
pi
fig
although
statist
signific
differ
compar
wt
virusinfect
mice
trend
faster
upregul
mrna
quit
clear
moreov
also
context
mous
model
transcript
level
ifn
cytokin
slightli
decreas
dubneg
rmerscovinfect
mice
day
pi
wt
rmerscovinfect
mice
mrna
level
extrem
upregul
fig
therefor
hypothes
differ
surviv
rate
like
due
acceler
induct
properli
regul
innat
immun
respons
dubneg
virusinfect
mice
like
effect
clear
viru
prevent
tissu
damag
protect
mice
lethal
fig
contrast
respons
wt
virusinfect
mice
first
suppress
later
time
point
extrem
upregul
fig
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mean
per
group
present
dash
line
repres
averag
set
mockinfect
mice
statist
signific
wt
dubneg
merscovinfect
mice
shown
p
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
